NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...
HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of a curative regimen for human immunodeficiency virus (HI ...
Budget 2025 hopes to extend financial incentives to clinical research industry for developing cutting-edge therapies in India ...
The COVID-19 pandemic forced investigators conducting clinical trials to use decentralized elements, such as telehealth, to ...
Asian News International on MSN2d
CliniExperts Conducts Successful Study, Affirming ALFLUTOP®'s Benefits for Indian Osteoarthritis PatientsCliniExperts, one of India's premier Clinical Research Organizations, successfully conducted a phase III study on its ...
Vedanta Biosciences has published additional results from its Phase 2 CONSORTIUM study for VE303, a potential first-in-class ...
New Delhi: Sun Pharma Labs has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug ...
Keytruda (pembrolizumab) plus Lenvima (lenvatinib) and chemotherapy improved progression-free survival but did not achieve ...
Alexander I. Spira, MD, PhD, FACP, discusses the clinical implications of ctDNA for treatment decisions and monitoring in ...
The MM120 ODT Phase 3 clinical development program also includes the Voyage study for GAD and the Emerge study for major depressive disorder (MDD). The U.S. Food and Drug Administration has granted ...
clinicaltrialsarena on MSN6d
Medidata extends partnership with Tigermed to enhance clinical trial processesMedidata has announced the extension of its partnership of 13 years with Tigermed to enhance clinical trial processes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback